Your browser doesn't support javascript.
loading
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function.
Marino, Mariapaola; Bartoccioni, Emanuela; Alboini, Paolo Emilio; Evoli, Amelia.
Affiliation
  • Marino M; Istituto di Patologia Generale, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Bartoccioni E; Istituto di Patologia Generale, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Alboini PE; Istituto di Neurologia, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Evoli A; Istituto di Neurologia, Università Cattolica del Sacro Cuore, Rome, Italy.
Ann N Y Acad Sci ; 1413(1): 41-48, 2018 02.
Article in En | MEDLINE | ID: mdl-29369382
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / CD4-Positive T-Lymphocytes / CD8-Positive T-Lymphocytes / Rituximab / Immunologic Factors / Myasthenia Gravis Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann N Y Acad Sci Year: 2018 Document type: Article Affiliation country: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / CD4-Positive T-Lymphocytes / CD8-Positive T-Lymphocytes / Rituximab / Immunologic Factors / Myasthenia Gravis Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann N Y Acad Sci Year: 2018 Document type: Article Affiliation country: Italy